These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 21937093

  • 1. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
    Lawrie AS, Hills J, Longair I, Green L, Gardiner C, Machin SJ, Cohen H.
    Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
    [Abstract] [Full Text] [Related]

  • 2. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M, Daniel D, Farrelly B, Coghlan D, Gallus A.
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [Abstract] [Full Text] [Related]

  • 3. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A, Ignjatovic V, Summerhayes R, Newall F, Burgess J, DeRosa L, Monagle P.
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [Abstract] [Full Text] [Related]

  • 4. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
    Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, Johnston M, Larkin EC.
    Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
    [Abstract] [Full Text] [Related]

  • 5. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q, Kim JE, Hyun J, Han KS, Kim HK.
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [Abstract] [Full Text] [Related]

  • 6. Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic.
    Colella MP, Fiusa MM, Orsi FL, de Paula EV, Annichino-Bizzacchi JM.
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):172-4. PubMed ID: 22246165
    [Abstract] [Full Text] [Related]

  • 7. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M, Hillarp A, Strandberg K, Nilsson C, Svensson PJ.
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK.
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
    Bauman ME, Black KL, Massicotte MP, Bauman ML, Kuhle S, Howlett-Clyne S, Cembrowski GS, Bajzar L.
    Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
    [Abstract] [Full Text] [Related]

  • 11. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
    Baruch L, Sherman O.
    Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
    [Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
    Phillips EM, Buchan DA, Newman N, Rajan A, Zia S.
    Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
    [Abstract] [Full Text] [Related]

  • 13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M, Hillarp A, Svensson P.
    Thromb Res; 2004 Oct; 114(2):83-9. PubMed ID: 15306149
    [Abstract] [Full Text] [Related]

  • 14. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting.
    Williams VK, Griffiths AB.
    Pathology; 2007 Dec; 39(6):575-9. PubMed ID: 18027261
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS, McBane RD, Chaudhry R, Beyer LK, Santrach PJ.
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [Abstract] [Full Text] [Related]

  • 16. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
    Bonar R, Mohammed S, Favaloro EJ.
    Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG, Si Moussi T, Berge N, Bal Dit Sollier C, Henry P, Drouet L.
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic.
    Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH.
    Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.